[Back to Number 6 ToC] [Back to Journal Contents] [Back to Biokhimiya Home page]
[View Full Article] [Download Reprint (PDF)]

Modulation of Mast Cell Activity by a Peptide Agonist of the Thrombin Receptor: Role of Nitric Oxide

S. M. Strukova1*, I. V. Chistov1, B. A. Umarova1, T. N. Dugina1, T. P. Storozhevykh2, V. G. Pinelis2, and E. Glusa3

1Department of Human and Animal Physiology, School of Biology, Lomonosov Moscow State University, Moscow, 119899 Russia; tel.: (095) 939-1416

2Laboratory of Membranology, Institute of Pediatrics, Russian Academy of Medical Sciences, Lomonosovsky pr. 2/62, Moscow, 117963 Russia; tel.: (095) 134-1445

3Center for Vascular Biology and Medicine, Friedrich Schiller Iena University, Erfurt, Germany

* To whom correspondence should be addressed.

Received June 23, 1998; Revision received November 5, 1998
The effect of a thrombin receptor agonist peptide (TRAP-6) on the release of nitric oxide (NO) and platelet activating factor (PAF) from resting and calcium-ionophore (A23187)-activated rat peritoneal mast cells (RPMC) was studied using a platelet aggregation bioassay. RPMC spontaneously released NO, which inhibited TRAP-6-, ADP-, and PAF-stimulated platelet aggregation. This effect of NO was abolished by the addition of an NO binding agent, oxyhemoglobin (oxyHb), to the platelet suspension. The RPMC-induced suppression of platelet aggregation was completely inhibited by the NO-synthase inhibitor L-NAME. TRAP-6 and its high affinity analog haTRAP stimulated the rapid release of NO from RPMC. The effect of TRAP-6 was inhibited by pretreatment of the RPMC with L-NAME or with the inhibitor of the constitutive NO-synthase isoform (cNOS) calmidazolium. TRAP-6 inhibited PAF release from A23187-activated RPMC via an NO-dependent mechanism. Platelet aggregation induced by PAF release from activated RPMC was also confirmed in experiments using the PAF receptor antagonist ginkgolide B. Thus, TRAP-6 is a rapidly acting modulator of mast cell reactivity; it stimulates NO release and inhibits PAF secretion.
KEY WORDS: thrombin receptor agonist peptide, mast cells, nitric oxide, platelet activating factor